Cargando…
D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review
D-Cycloserine, known from tuberculosis therapy, has been widely introduced to neuropsychiatric studies, since its central active mechanism as a partial NMDA-agonist has been found. In this review, we evaluate its therapeutic potential in neuropsychological disorders and discuss its pitfalls in terms...
Autores principales: | Schade, Sebastian, Paulus, Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851259/ https://www.ncbi.nlm.nih.gov/pubmed/26364274 http://dx.doi.org/10.1093/ijnp/pyv102 |
Ejemplares similares
-
Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis
por: Court, Richard, et al.
Publicado: (2021) -
Cycloserine induced mania
por: Bakhla, Ajay Kumar, et al.
Publicado: (2013) -
D-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders
por: Hofmann, Stefan G, et al.
Publicado: (2013) -
d-Cycloserine destruction by alanine racemase and the limit of irreversible inhibition
por: de Chiara, Cesira, et al.
Publicado: (2020) -
Substrate Reduction Therapy for Krabbe Disease: Exploring the Repurposing of the Antibiotic D-Cycloserine
por: LeVine, Steven M., et al.
Publicado: (2022)